Skip to main content
. 2024 Mar 15;110(6):3527–3535. doi: 10.1097/JS9.0000000000001276

Table 1.

Baseline characteristic in the derivation and validation cohort.

All (n=10 993) Derivation cohort (n=7695) Testing cohort (n=3298) P
Age (years), median (IQR) 53.00 (30.00) 53.00 (31.00) 53 (29.00) 0.2882
Sex (n, %)
 Male 5864 (53.34) 4097 (53.24) 1767 (53.58) 0.7466
 Female 5129 (46.66) 3598 (46.76) 1531 (46.42)
BMI, median (IQR) 21.26 (4.00) 21.25 (3.68) 21.28 (3.89) 0.3315
Drink (n, %) 971 (8.83) 649 (8.43) 322 (9.76) 0.0244
Smoke (n, %) 1158 (10.53) 795 (10.33) 363(11.01) 0.2906
Abdominal surgery history (n, %) 2222 (20.21) 1560 (20.27) 662(20.07) 0.8108
Hypertension (n, %) 1299 (11.82) 899 (11.68) 400 (12.13) 0.5071
Diabetes (n, %) 712 (6.48) 497 (6.46) 215 (6.52) 0.9062
COPD (n, %) 136 (1.24) 91 (1.18) 45 (1.36) 0.4292
Chronic kidney disease (n, %) 168 (1.53) 123 (1.60) 45 (1.36) 0.3594
Nervous system disease (n, %) 196 (1.78) 136 (1.77) 60 (1.82) 0.8505
Cancer (n, %) 437 (3.98) 304 (3.95) 133 (4.03) 0.8399
Cardiovascular disease (n, %) 533 (4.85) 377 (4.90) 156 (4.73) 0.7052
Steroid use (n, %) 101 (0.92) 74 (0.96) 27 (0.82) 0.4715
Surgical sepsis
 None (n, %) 10167 (92.49) 7127 (92.62) 3040 (92.18) 0.2146
 Sepsis only (n, %) 559 (5.09) 394 (5.12) 165 (5.00)
 Septic shock (n, %) 267 (2.43) 174 (2.26) 93 (2.82)
Laboratory test, median (IQR)
 WBC (109 /l) 9.20 (6.81) 9.20 (6.79) 9.20 (6.88) 0.8410
 RBC (109 /l) 4.29 (0.84) 4.29 (0.84) 4.29 (0.86) 0.9879
 PLT (109 /l) 198.00 (85.50) 198.00 (86.00) 197.00 (84.00) 0.2929
 Hct (%) 38.70 (7.30) 38.80 (7.30) 39.60 (7.40) 0.5308
 Hb (g/l) 129.00 (27.00) 129.00 (27.00) 129.00 (27.00) 0.5146
 ALT (U/l) 20.00 (17.00) 20.00 (17.00) 20.00 (17.00) 0.7527
 AST (U/l) 21.00 (11.00) 21.00 (10.00) 21.00 (11.00) 0.3773
 TBil (μmol/l) 16.37 (12.60) 16.31 (12.60) 16.40 (12.70) 0.8059
 ALB (g/l) 39.70 (7.00) 39.62 (7.00) 39.76 (7.10) 0.4501
 Crea (μmol/l) 69.30 (26.50) 69.30 (26.90) 69.30 (25.80) 0.4927
 BUN (mmol/l) 5.25 (2.90) 5.27 (2.90) 5.20 (2.92) 0.8997
 Na+ (mmol/l) 139.80 (4.00) 139.80 (4.00) 139.80 (3.90) 0.6138
 K+ (mmol/l) 3.91 (0.54) 3.91 (0.54) 3.92 (0.52) 0.9869
 TCO2 (mmol/l) 23.30 (3.50) 23.30 (3.50) 23.30 (3.50) 0.3941
 PT (s) 13.60 (1.80) 13.60 (1.80) 13.60 (1.90) 0.1379
 INR 1.08 (0.18) 1.08 (0.18) 1.08 (0.18) 0.3484
AAST EGS Grade (n, %)
 1 6073 (55.24) 4274 (55.54) 1799 (54.55) 0.7571
 2 1151 (10.47) 811 (10.54) 340 (10.31)
 3 1501 (13.65) 1032 (13.41) 469 (14.22)
 4 1093 (9.94) 763 (9.29) 330 (10.01)
 5 1175 (10.69) 815 (10.59) 360 (10.92)
ASA classification (n, %)
 1 658 (5.99) 441 (5.73) 217 (6.58) 0.1999
 2 7358 (66.93) 5193 (67.49) 2165 (65.65)
 3 2796 (25.43) 1939 (25.20) 857 (25.99)
 4 167 (1.52) 111 (1.44) 56 (1.70)
 5 14 (0.13) 11 (0.14) 3 (0.09)
ESS, median (IQR) 2.00 (2.00) 2.00 (2.00) 2.00 (2.00) 0.6812
APACHE II, median (IQR) 4.00 (4.00) 4.00 (4.00) 4.00 (4.00) 0.9143
In-hospital events
 Postoperative Mortality (n, %) 153 (1.39) 107 (1.39) 46 (1.39) 0.9860
 Postoperative pneumonia (n, %) 632 (5.75) 432 (5.61) 200 (6.06) 0.3527
 Postoperative SSI (n, %) 531 (4.83) 390 (5.07) 141 (4.28) 0.0756
 Postoperative thrombosis (n, %) 616 (5.60) 427 (5.55) 189 (5.73) 0.7043
 Postoperative mechanical ventilation > 48 h (n, %) 674 (6.13) 470 (6.11) 204 (6.19) 0.8763

AAST, American Association for the Surgery of Trauma; ALB, albumin; ALT, alanine aminotransferase; APACHE II, Acute Physiology and Chronic Health Evaluation II; ASA, American Society of Anesthesiologists; AST, aspartate aminotransferase; BUN, blood urea nitrogen; COPD, chronic obstructive pulmonary disease; Crea, creatinine; EGS, emergency general surgery; ESS, Emergency Surgery Score; Hb, hemoglobin; Hct, hematocrit; INR, international normalized ratio; IQR, interquartile range; K+, potassium ion; Na+, sodium ion; PLT, platelet; PT, prothrombin time; RBC, red blood cell; SSI, surgical site infection; TBIL, total bilirubin; TCO2, total carbon dioxide; WBC, white blood cell.